Edition:
United States

Insider Trading: Gilead Sciences Inc (GILD.O)

GILD.O on Nasdaq

85.82USD
27 May 2016
Change (% chg)

-- (--)
Prev Close
$85.82
Open
--
Day's High
--
Day's Low
--
Volume
352
Avg. Vol
11,840,932
52-wk High
$123.37
52-wk Low
$81.28

ANDERSON KRISTEN METZA

Institutional Holders

% Shares Owned: 81.90%
# of Holders: 2,232
Total Shares Held: 1,090,759,308
3 Mo. Net Change: -69,472,198
# New Positions: 113
# Closed Positions: 117
# Increased Positions: 937
# Reduced Positions: 891
# Net Buyers: 46

Officers & Directors

Name Age Since Current Position

John Martin

64 2016 Executive Chairman of the Board

John Milligan

54 2016 Chief Executive Officer, Director

Robin Washington

53 2014 Chief Financial Officer, Executive Vice President

Kevin Young

55 2016 Chief Operating Officer

Norbert Bischofberger

60 2007 Executive Vice President - Research and Development, Chief Scientific Officer

Kathleen Watson

2016 Executive Vice President - Human Resources

Gregg Alton

50 2009 Executive Vice President - Corporate and Medical Affairs

Martin Silverstein

48 2016 Executive Vice President - Strategy

John Cogan

68 2013 Lead Independent Director

Kevin Lofton

61 2009 Independent Director

John Madigan

78 2005 Independent Director

Nicholas Moore

74 2004 Independent Director

Richard Whitley

70 2008 Independent Director

Gayle Wilson

73 2001 Independent Director

Per Wold-Olsen

68 2010 Independent Director